相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally
Jason G. Fewell et al.
JOURNAL OF GENE MEDICINE (2009)
A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma
Adam M. Sonabend et al.
ANTI-CANCER DRUGS (2008)
Immunotherapy opportunities in ovarian cancer
Christina S. Chu et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
Renato Lenzi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer: Efficacy, Toxicity, and Future Directions
Maurie Markman
REVIEWS ON RECENT CLINICAL TRIALS (2007)
Biodistribution and Cearance Following Intraperitoneal Injection of Murine Interleukin-12 Plasmid Formulated with a Novel Polymeric Delivery System
Elaine Brunhoeber et al.
MOLECULAR THERAPY (2006)
Safety and Toxicity Following Intraperitoneal Injection of Murine Interleukin-12 Plasmid Formulated with a Novel Polymeric Delivery System
Jason G. Fewell et al.
MOLECULAR THERAPY (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer
JG Fewell et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma
PL Triozzi et al.
HUMAN GENE THERAPY (2005)
Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: Clinical efficacy
L Heinzerling et al.
HUMAN GENE THERAPY (2005)
Percutaneous placement of peritoneal port-catheter in oncologic patients
F Orsi et al.
EUROPEAN RADIOLOGY (2004)
Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2:: Coordination of dendritic and CD8+ cell responses
WJ Murphy et al.
JOURNAL OF IMMUNOLOGY (2003)
Synergistic engagement of an ineffective endogenous anti-tumor immune response and induction of IFN-γ and Fas-ligand-dependent tumor eradication by combined administration of IL-18 and IL-2
JM Wigginton et al.
JOURNAL OF IMMUNOLOGY (2002)
Interleukin-12-gene transduction makes DCs from tumor-bearing mice an effective inducer of tumor-specific immunity in a peritoneal dissemination model
K Furumoto et al.
IMMUNOLOGY LETTERS (2002)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Antitumoral effect of interleukin-12-secreting fibroblasts in a mouse model of ovarian cancer: Implications for the use of ovarian cancer biopsy-derived fibroblasts as a vehicle for regional gene therapy
R Sanches et al.
CANCER GENE THERAPY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
